OP30: Serum proteomic profiling predicts and diagnoses pouchitis in ulcerative colitis patients undergoing ileal pouch-anal anastomosisECCO'19 Copenhagen 2019
1
OP34: VARSITY: A Double-Blind, Double-Dummy, Randomised, Controlled Trial of Vedolizumab Versus Adalimumab in Patients With Active Ulcerative ColitisECCO'19 Copenhagen 2019
1
OP35: Endoscopic and Deep Remission at 1 Year Prevents Disease Progression in Early Crohn’s Disease: Long-Term Data from CALMECCO'19 Copenhagen 2019
1
OP37: Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFIECCO'19 Copenhagen 2019
1
OP38: Maintenance treatment with mirikizumab, a p19-directed IL-23 antibody: 52-week results in patients with moderately-to-severely active ulcerative colitisECCO'19 Copenhagen 2019
1
Optimal management of patient with Severe Crohn's Disease treated with anti-TNF agents17th IBD Intensive Advanced Course 2019
1
Outcomes from the ECCO Fellowship 2018: Monocyte-derived macrophages as crucial players in the resolution of inflammation and tissue repair in Inflammatory Bowel DiseaseECCO'19 Copenhagen 2019
1
Outcomes from the ECCO Fellowship 2018: Role of TNF-inducible gene-6 (TSG-6) in fistulising Crohn's DiseaseECCO'19 Copenhagen 2019
1
Outcomes from the ECCO Pioneer Award 2017: Faecal transplantation using a novel conditioning method for donor and recipient in mild to moderate treatment refractory colitis in Inflammatory Bowel DiseaseECCO'19 Copenhagen 2019
1
Outcomes of the ECCO-IOIBD Fellowship 2017: Precision medicine for IBD using advanced machine learningECCO'19 Copenhagen 2019
Outcomes of the ECCO-IOIBD Fellowship 2018 Deciphering the gut-specific B cell response in Inflammatory Bowel DiseaseECCO'19 Copenhagen 2019
1
Patient perspectives of guidelines - why should patients be involved1st Guideline Methodology and GRADE Workshop 2019
1